Predictors of nonuse of a high-potency statin after an acute coronary syndrome: Insights from the stabilization of plaques using darapladib-thrombolysis in myocardial infarction 52 (SOLID-TIMI 52) trial

Alon Eisen, Christopher P. Cannon, Eugene Braunwald, Dylan L. Steen, Jing Zhou, Erica L. Goodrich, Kyung Ah Im, Anthony J. Dalby, Jindrich Spinar, Shruti Daga, Mary Ann Lukas, Michelle L. O'Donoghue*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Predictors of nonuse of a high-potency statin after an acute coronary syndrome: Insights from the stabilization of plaques using darapladib-thrombolysis in myocardial infarction 52 (SOLID-TIMI 52) trial'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science